VTVT
vTv Therapeutics Inc.
There isn't enough reported data to score VTVT yet.
VTVT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VTVT's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
VTVT PE Valuation
VTVT has no meaningful PE right now: it lost money over the past year.
VTVT Forward outlook
There aren't enough analyst estimates for VTVT to show an outlook.
VTVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.11 | +$3.09 |
| Q1 2026 | $0.02 | +$3.11 |
| Q4 2025 | -$3.62 | -$0.13 |
| Q3 2025 | -$3.40 | +$1.13 |
| Q2 2025 | -$3.20 | +$3.72 |
| Q1 2025 | -$3.09 | +$5.78 |
| Q4 2024 | -$3.49 | +$6.42 |
| Q3 2024 | -$4.53 | +$6.04 |
VTVT lost $0.11 per share over the past year, a smaller loss than the year before.
VTVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $9K | 0% |
| Q2 2022 | $9K | 0% |
| Q1 2022 | $2M | +103% |
| Q4 2021 | $9K | -100% |
| Q3 2021 | $3M | +42757% |
| Q1 2021 | $987K | +12238% |
| Q4 2020 | $6.4M | +91314% |
VTVT's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | 63% | N/A |
| Q4 2024 | -28776% | N/A |
| Q1 2024 | -563% | N/A |
| Q4 2022 | -70478% | +52956 points |
| Q2 2022 | -44744% | +7144 points |
| Q1 2022 | -324% | +110 points |
| Q4 2021 | -123433% | -123462 points |
| Q3 2021 | -53% | +40404 points |
VTVT's operating margin was 63% last quarter, up 44808 points from the same quarter a year ago, near the top of its range since 2019.
VTVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.2M | -$5M |
| Q2 2026 | -$11.4M | -$6.3M |
| Q1 2026 | $9.2M | +$14.8M |
| Q4 2025 | -$9.3M | -$4.4M |
| Q3 2025 | -$5.2M | +$1.2M |
| Q2 2025 | -$5.1M | +$1.6M |
| Q1 2025 | -$5.7M | +$1.6M |
| Q4 2024 | -$4.8M | -$1.9M |
VTVT has burned cash in almost every quarter: −$22M over the past year, against −$21M the year before.
VTVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +47% | +4M shares |
| 1 year | +88% | +5.8M shares |
| 3 years | +509% | +10.4M shares |
| 5 years | +747% | +10.9M shares |
| Available history | +1208% | +11.5M shares |
VTVT has 12M diluted shares, up 88% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
VTVT hasn't bought back shares in the past year.
VTVT Net Leverage
VTVT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VTVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 3.6 | Oversold |
VTVT's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
VTVT PE vs Healthcare Sector
| Metric | VTVT | Sector median | Relative |
|---|---|---|---|
| PE | 1,559x | 26x | 5,931% above |
| PE % | 19 | 29 | 10 pts below |
VTVT has no meaningful PE right now: it lost money over the past year.
VTVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 22% below |
| 20 week MA | $30.2 | 31% below |
| 50 week MA | $33.0 | 37% below |
| 100 week MA | $25.8 | 20% below |
| 200 week MA | $23.5 | 12% below |
VTVT is in a downtrend: it's below all five of its weekly moving averages, and 12% below its 200-week average.
VTVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $71.6 | $82.0 | +15% |
| 2021 | $82.0 | $43.2 | -47% |
| 2022 | $43.2 | $27.2 | -37% |
| 2023 | $27.2 | $11.5 | -58% |
| 2024 | $11.5 | $13.2 | +15% |
| 2025 | $13.2 | $37.9 | +187% |
| 2026 YTD | $37.9 | $20.7 | -45% |
VTVT's yearly returns have swung widely, from +187% in 2025 to −58% in 2023. It's down 45% so far in 2026.